• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本新冠疫情期间,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)未通过牙科诊所传播。

SARS-CoV-2 Did Not Spread Through Dental Clinics During the COVID-19 Pandemic in Japan.

作者信息

Tsubura Yasuhiro, Komiyama Yuske, Ohtani Saori, Hyodo Toshiki, Shiraishi Ryo, Yagisawa Shuma, Yaguchi Erika, Tsubura-Okubo Maki, Houzumi Hajime, Nemoto Masato, Kikuchi Jin, Fukumoto Chonji, Izumi Sayaka, Wakui Takahiro, Wake Koji, Kawamata Hitoshi

机构信息

Department of Oral and Maxillofacial Surgery, School of Medicine, University of Dokkyo Medical, 880 Kitakobayashi Mibu Shimotsuga, Tochigi 321-0293, Japan.

Yasu Kazu Charm Dental Clinic, 2-4-35 Takinohara Utsunomiya, Tochigi 320-0846, Japan.

出版信息

Infect Dis Rep. 2025 Jun 13;17(3):70. doi: 10.3390/idr17030070.

DOI:10.3390/idr17030070
PMID:40559201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193509/
Abstract

BACKGROUND

Dental professionals were thought to have the most significant risk of coronavirus infection during the pandemic. Since the first Coronavirus Disease 2019 (COVID-19) patient was detected in Japan in January 2020, Japan has faced several waves of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. However, no cluster of SARS-CoV-2 infections associated with dental procedures has been reported in Japan. In this study, we aimed to investigate the actual status of SARS-CoV-2 infection during the pandemic through antibody testing for dental professionals. We further investigated saliva and oral management-related aerosol to estimate the risk of virus transmission during dental procedures.

METHODS

SARS-CoV-2 antibody titer in the blood of dental professionals and their families was determined during the pre-vaccinated period of the SARS-CoV-2 wave to see the history of infection in Japan. Viral loads in saliva and in the aerosol generated during the oral management of COVID-19 patients were detected by RT-qPCR.

RESULTS

The antibody testing of dental healthcare providers during the early phases of the pandemic in Japan revealed low antibody positivity, which supported the low incidence of infection clusters among dental clinics. The aerosol generated during dental procedures may contain trace levels of SARS-CoV-2, indicating the risk of transmission through dental procedures is limited. Therefore, SARS-CoV-2 did not spread through dental clinics.

CONCLUSIONS

Very few SARS-CoV-2 infections were observed in dental professionals who took appropriate infection control measures in the early period of the pandemic. Performing dental procedures using standard precautions seems to be sufficient to prevent SARS-CoV-2 infections.

摘要

背景

在疫情期间,牙科专业人员被认为感染冠状病毒的风险最高。自2020年1月日本发现首例2019冠状病毒病(COVID-19)患者以来,日本已面临多波严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染。然而,日本尚未报告与牙科诊疗相关的SARS-CoV-2感染聚集性病例。在本研究中,我们旨在通过对牙科专业人员进行抗体检测,调查疫情期间SARS-CoV-2感染的实际情况。我们还进一步研究了唾液和口腔操作相关气溶胶,以评估牙科诊疗过程中病毒传播风险。

方法

在SARS-CoV-2流行的疫苗接种前时期,测定牙科专业人员及其家属血液中的SARS-CoV-2抗体滴度,以了解日本的感染史。通过逆转录定量聚合酶链反应(RT-qPCR)检测COVID-19患者口腔操作过程中产生的唾液和气溶胶中的病毒载量。

结果

日本疫情早期对牙科医护人员的抗体检测显示抗体阳性率较低,这支持了牙科诊所感染聚集性病例发生率较低的情况。牙科诊疗过程中产生的气溶胶可能含有微量的SARS-CoV-2,表明通过牙科诊疗传播的风险有限。因此,SARS-CoV-2未在牙科诊所传播。

结论

在疫情早期采取适当感染控制措施的牙科专业人员中,很少观察到SARS-CoV-2感染。采用标准预防措施进行牙科诊疗似乎足以预防SARS-CoV-2感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a5f/12193509/f88c9ca98e57/idr-17-00070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a5f/12193509/bfb633312812/idr-17-00070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a5f/12193509/f88c9ca98e57/idr-17-00070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a5f/12193509/bfb633312812/idr-17-00070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a5f/12193509/f88c9ca98e57/idr-17-00070-g002.jpg

相似文献

1
SARS-CoV-2 Did Not Spread Through Dental Clinics During the COVID-19 Pandemic in Japan.在日本新冠疫情期间,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)未通过牙科诊所传播。
Infect Dis Rep. 2025 Jun 13;17(3):70. doi: 10.3390/idr17030070.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers.口腔预处理冲洗液在预防牙科医护人员通过气溶胶传播传染性疾病中的应用。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013826. doi: 10.1002/14651858.CD013826.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Hyperimmune immunoglobulin for people with COVID-19.COVID-19 免疫球蛋白
Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD015167. doi: 10.1002/14651858.CD015167.pub2.
9
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
10
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.

本文引用的文献

1
Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis.自然血清转化的口腔医护人员中SARS-CoV-2抗体的血清流行率:一项系统评价和荟萃分析。
Sci Rep. 2025 Mar 6;15(1):7848. doi: 10.1038/s41598-025-91529-4.
2
Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review.基于当前证据的严重急性呼吸综合征冠状病毒2的最小感染剂量:一项系统综述。
SAGE Open Med. 2022 Aug 11;10:20503121221115053. doi: 10.1177/20503121221115053. eCollection 2022.
3
Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols.
牙科气溶胶中 SARS-CoV-2 和其他微生物的来源。
J Dent Res. 2021 Jul;100(8):817-823. doi: 10.1177/00220345211015948. Epub 2021 May 12.
4
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.仅有 2%的 SARS-CoV-2 阳性个体携带了在社区中传播的 90%的病毒。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2104547118.
5
Ten scientific reasons in support of airborne transmission of SARS-CoV-2.支持新冠病毒空气传播的十个科学依据。
Lancet. 2021 May 1;397(10285):1603-1605. doi: 10.1016/S0140-6736(21)00869-2. Epub 2021 Apr 15.
6
SARS-CoV-2 infection of the oral cavity and saliva.SARS-CoV-2 对口腔和唾液的感染。
Nat Med. 2021 May;27(5):892-903. doi: 10.1038/s41591-021-01296-8. Epub 2021 Mar 25.
7
Brief communication: Immunohistochemical detection of ACE2 in human salivary gland.简短通讯:人唾液腺中ACE2的免疫组织化学检测
Oral Sci Int. 2021 May;18(2):101-104. doi: 10.1002/osi2.1085. Epub 2020 Sep 28.
8
Possible aerosol transmission of COVID-19 and special precautions in dentistry.新型冠状病毒肺炎(COVID-19)可能的气溶胶传播途径与牙科操作的特殊防护措施
J Zhejiang Univ Sci B. 2020 May;21(5):361-368. doi: 10.1631/jzus.B2010010. Epub 2020 Mar 16.